Home > Drug Testing State Laws > New York Workers' Comp Drug Testing Laws

 

 

Share This Page:

Sponsor: Third-Party Administrator
Visit Broadspire for Workers Compensation 3rd-Party Administrator Services (opens in new window)
Claim Administrator &
Medical Management

Sponsor: Medcor
Click for Onsite Wellness Clinics, Nurse Triage, Pre-employment Screening (opens in new window)
Onsite Wellness Clinics, Nurse Triage, Pre-employment Screening

 


New York Drug Testing and Workers' Comp Laws

    New York Workers' Compensation Laws and Regulations of this State
New York Workers' Compensation Laws and Regulations


Official New York Website
   
 

NEW YORK State Law Summary - Workplace Drug/Alcohol Testing 

GENERAL COMMENTS: New York is a "mandatory" state, with method of testing requirements.

POLICY: NO law requires a written policy; however, for workers compensation/unemployment purposes employers SHOULD have written policy.

NOTICE: NO notice or posting requirements in this state.

COSTS: Not specified.

CONSEQUENCES: NO limits exist under state law or court decision.

TESTING
WHO:
NO limits exist under state law or court decision.

WHAT: NO limits exist under state law or court decision.

WHERE: NO limits exist under state law or court decision, but required state test methods may limit where testing is conducted.

WHEN: NO limits exist under state law or court decision.

HOW: All tests of any part of the human body must meet state test methods and procedures.

OTHER STATE PECULIARITIES: No significant other laws directly related to workplace drug/alcohol testing.

Updated 11/21/11



The material on this page has been provided by our resource partner Park-Dickens Group, distributor of FIGHTREADY™, an automated process for state specific, post-accident policies and procedures to help defend against workers' comp claims involving drug and alcohol intoxication. For a copy of the state laws, regulations, statutes, court decisions, or cases involved, email Bill Judge.

WARNING: This information is presented after a review of the statutes, regulations and court decisions in this state. This information is subject to frequent change and inherently involves our opinion in certain instances and you may disagree. This information is presented for general educational purposes only -- IT IS NOT INTENDED TO PROVIDE LEGAL OR OTHER PROFESSIONAL ADVICE.  Always consult your legal and medical professionals before making any decisions.



NOTE: The material below was last updated in 2010. For a copy of the statutes or cases involved, email Bill Judge.

NEW YORK State Drug Testing Laws
 

New York (Mandatory State) 

New York State Public Health Law

TITLE V

CLINICAL LABORATORY AND BLOOD BANKING SERVICES 

Sec. 570. Declaration of policy and statement of purpose.

571. Definitions.

572. Certificates of qualification.

573. Issuance of certificates of qualification.

574. Permits.

575. Issuance of permits.

576. Duties and powers of the department.

576-a. Clinical laboratories and cytotechnologists examining Pap smears.

576-b. Performance of certain clinical laboratory services upon request.

577. Enforcement.

578. Penalties.

579. Scope and exceptions.

580. Construction.

581. Separability. '

 

§570. Declaration of policy and statement of purpose.  

The proper performance of clinical laboratory and blood banking services is a matter of vital concern, affecting the public health, safety and welfare. Clinical laboratories and blood banks provide essential public health services in aiding the health care provider by furnishing information invaluable to the diagnosis and treatment of disease. The improper performance of a laboratory procedure may induce an erroneous diagnosis or contribute to the selection of an inappropriate method of treatment, resulting in prolonged or unnecessary hospitalization, injury or even death. The protection of the people of this state requires affirmative action to insure that the performance of clinical laboratory and blood banking services meet high standards of public health care. It is the purpose of this title to promote the public health, safety and welfare by requiring the licensure of clinical laboratories and blood banks, by establishing minimum qualifications for directors, and by requiring that the performance of all procedures employed by clinical laboratories and blood banks meet minimum standards accepted and approved by the department. '

 

§571. Definitions. As used in this title: [REV. 9/22/03 1] 

1. "Clinical laboratory" means a facility for the microbiological, immunological, chemical, hematological, biophysical, cytological, pathological, genetic, or other examination of materials derived from the human body, or the purpose of obtaining information for the diagnosis, prevention, or treatment of disease or the assessment of a health condition or for identification purposes. Such examinations shall include procedures to determine, measure or otherwise describe the presence or absence of various substances, components or organisms in the human body. The term clinical laboratory shall not include any facility or activity specifically excluded by section five hundred seventy-nine of this title.  

2. "Blood bank" means a facility for the collection, processing, storage and/or distribution of human blood, blood components or blood derivatives.  

3. "Reference system" means a system of periodic testing of methods, procedures and materials of clinical laboratories and blood banks, including, but not limited to, the distribution of manuals of approved methods, inspection of facilities, cooperative research, and periodic submission of test specimens for examination.  

4. "Director" means the person who is responsible for administration of the technical and scientific operation of a clinical laboratory or blood bank, including supervision of procedures and reporting of findings of tests. '

 

572. Certificates of qualification.  

No person shall act as a director in a clinical laboratory located in or accepting specimens from New York state or in a blood bank located in or collecting, processing, storing or distributing blood products in New York state unless a valid certificate of qualification has been issued as provided in section five hundred seventy-three of this title. A certificate shall be issued authorizing the holder to perform or direct one or more procedures or one or more categories of such procedures. '

 

§573. Issuance of certificates of qualification.  

1. The public health council shall prescribe minimum qualifications for directors in areas of testing, including, but not limited to, microbiology, immunology, chemistry, hematology, biophysics, cytology, pathology, genetics and blood banking.  

2. The department shall issue a certificate of qualification to any person who meets such minimum qualifications and who otherwise demonstrates to the department that such person possesses the character, competence, training and ability to administer properly the technical and scientific operation of a clinical laboratory or blood bank, including supervision of procedures and reporting of findings of tests.  

3. Application for a certificate of qualification shall be made on forms provided by the department and shall contain the procedures or categories of procedures for which the certificate is sought and such other information as the department may require.  

4. The certificate shall be valid for a period of two years from the date of issuance and may be renewed for successive two year periods thereafter. The original application and each renewal application shall be accompanied by a registration fee of forty dollars. [REV. 9/22/03 2] 

5. Notwithstanding the provisions of this section, the commissioner may issue a temporary certificate of qualification to any person pending the issuance of a certificate as provided in this section. A temporary certificate shall be valid for a period of thirty days from the date of its issuance and may be renewed for a maximum of four successive periods of thirty days.

 

§574. Permits.  

No person shall own or operate a clinical laboratory located in or accepting specimens from New York state or own or operate a blood bank which collects, processes, stores and/or distributes, human blood, blood derivatives or blood components, in New York state unless a valid permit has been issued as provided in section five hundred seventy-five of this title. A permit shall be issued authorizing the performance of one or more procedures or services within one or more categories. A separate permit shall be required for each facility at which clinical laboratory tests are to be performed or at which a blood bank is to be operated, provided, however that the department may adopt regulations not inconsistent with the federal clinical laboratory improvement act of nineteen hundred eighty-eight authorizing an owner to operate more than one facility under a single permit.

 

§575. Issuance of permits.  

1. Application for a permit shall be made by the owner and the director of the clinical laboratory or blood bank upon forms provided by the department. The application shall contain the name of the owner, the name of the director, the procedures or categories of procedures or services for which the permit is sought, the location or locations and physical description of the facility or location or locations at which tests are to be performed or at which a blood bank is to be operated, and such other information as the department may require.  

2. A permit shall not be issued unless a valid certificate of qualification in the category of procedures for which the permit is sought has been issued to the director pursuant to the provisions of section five hundred seventy-three of this title, and unless the department finds that the clinical laboratory or blood bank is competently staffed and properly equipped, and will be operated in the manner required by this title.  

3. The permit shall be issued jointly to the owner and the director and they jointly and severally shall be responsible to the department for the maintenance and operation of the clinical laboratory or blood bank and for any violations of this title and the rules and regulations promulgated thereunder.  

4. A permit shall be valid for the year for which it is issued. The initial application for a permit shall be accompanied by a registration fee of one hundred dollars.

5. The permit shall specify the names of the owners and the director, the procedures or categories of procedures or services authorized, and the locations at which such procedures or services may be performed. The permit and the certificate of qualification shall be displayed at all times in a prominent place in the laboratory. 6. A permit shall become void by a change in the director, owner, or location. The department may, pursuant to regulations adopted under this title, extend the date on which a permit shall become void for a period not to exceed sixty days from the date of a change of the director, owner or location. An application for a permit may be made at any time, in the manner provided by this section. REV. 9/22/03 3

 

§576. Duties and powers of the department.  

1. The department may inquire into the operation of clinical laboratories and blood banks and may conduct periodic

inspections and/or evaluations of facilities, methods, procedures, materials, staff and equipment to assess compliance with requirements set forth in this title, the regulations promulgated hereunder and local laws, codes or regulations as specified in subdivision three of section five hundred eighty of this title.  

2. The department may require clinical laboratories and blood banks to submit, in a form prescribed by the department, periodic reports of tests performed and such other information as the department may require to carry out the provisions of this title. The department may adopt regulations to require clinical laboratories and blood banks to report all serious adverse incidents which may be connected to the clinical laboratory or blood bank services provided. Such incident reports shall be deemed confidential in the same manner as such reports submitted pursuant to section twenty-eight hundred five-m of this chapter. The department may also require clinical laboratories and blood banks to submit lists of personnel who are employed to perform laboratory procedures and to notify the department promptly of any changes in such personnel.  

3. The department shall operate a reference system and shall prescribe standards for the examination of specimens. As part of such reference system, the department may require clinical laboratories and blood banks to analyze test samples submitted by the department and to report on the results of such analyses. The rules and regulations of the department shall prescribe the manner in which proficiency testing or analyses of samples shall be performed and reports submitted. Failure to meet department standards in proficiency testing shall result in termination of the permit in the category or categories of testing established by the department in regulation until remediation is achieved. Such standards shall be at least as stringent as federal standards promulgated under the federal clinical laboratory improvement act of nineteen hundred eighty-eight. Such failure and termination shall be subject to review in accordance with regulations adopted by the department.  

4. (a) The department may adopt and amend rules and regulations to effectuate the provisions and purposes of this title. Such rules and regulations shall establish inspection and reference fees for clinical laboratories and blood banks in amounts not exceeding the cost of the inspection and reference program for clinical laboratories and blood banks and shall be subject to the approval of the director of the budget.  

(b) In determining the fee charges to be assessed, the department shall, on or before May first of each year, compute the total actual costs for the preceding state fiscal year which were expended to operate and administer the duties of the department pursuant to this title. The department shall, at such time or times and pursuant to such procedure as it shall determine by regulation, bill and collect from each clinical laboratory and blood bank an amount computed by multiplying such total computed operating expenses of the department by a fraction the numerator of which is the gross annual receipts of such clinical laboratory or blood bank during such twelve month period preceding the date of computation as the department shall designate by regulation, and the denominator of which is the total gross annual receipts of all clinical laboratories or blood banks operating in the state during such period. REV. 9/22/03

(c) Each such clinical laboratory and blood bank shall submit to the department, in such form and at such times as the department may require, a report containing information regarding its gross annual receipts from the performance of tests or examination of specimens pursuant to a permit issued by the department in accordance with the provisions of section five hundred seventy-five of this title. The department may require additional information and audit and review such information to verify its accuracy.  

(d) Partial payments equal to one-quarter of the total amount billed, may be made on or before June thirtieth, September thirtieth, December thirty-first and March tenth of the fiscal year to which the billing relates.  

(e) On or before September fifteenth of each year, the department shall recompute the actual costs and expenses of the department for the preceding state fiscal year and shall, on or before October fifteenth send to each clinical laboratory and blood bank, a statement setting forth the amount due and payable by, or the amount computed to the credit of, such clinical laboratory or blood bank, computed on the basis of the above stated formula, except that for the purposes of such computation the fraction shall be multiplied against the total recomputed actual expenses of the department for such fiscal year. Any amount due shall be payable not later than thirty days following the date of such statement. Any credit shall be applied against any succeeding payment due.  

(f) The commissioner may waive all or any part of such fee charges for clinical laboratories or blood banks operated by local governments and for nonprofit clinical laboratories or blood banks performing examinations and analyses or providing services under contract with the state or its local governments.  

(g) Subject to the approval of the director of the budget, the commissioner shall charge adequate and reasonable fees for the periodic inspection of out-of-state clinical laboratories and blood banks, not exceeding the estimated additional costs incurred for out-of-state inspections under this title.  

5. The department, within the amounts appropriated, may employ inspectors, investigators, assistants and other employees or may contract with the city of New York to carry out the provisions of this title, set the compensation of such employees, within limits provided by law, and prescribe the duties of such employees.  

6. The commissioner may appoint one or more advisory committees of persons expert in the major categories of clinical laboratory procedures to advise the commissioner in connection with the qualifications of technical personnel employed and the use of appropriate procedures. Each such advisory committee shall include at least one designee of the commissioner of the department of health of the city of New York.  

7. The department may adopt rules or regulations applicable only to or in the city of New York which are designed to address special needs or circumstances existing in such city. The department shall consider the recommendations of the city of New York , or the department or board of health of such city, concerning the adoption or amendment of any such rules or regulations.  

8. The department may enter into agreements with the secretary of health and human services as authorized by the federal clinical laboratory improvement act of nineteen hundred eighty-eight and title XVIII of the social security act to perform such acts as may be necessary to assure conformance with such laws by laboratories operating in the state.

REV. 9/22/03 5

 

§576-a. Clinical laboratories and cytotechnologists examining Pap smears.  

1. Definitions. As used in this section, unless the context clearly requires otherwise, the following terms shall have the following meanings: (a) "Cytotechnologist". A clinical laboratory professional specializing in the analysis of cytopathology samples, including Pap smears, for cervical cancer and related diseases who meets the qualifications specified by the department.

(b) "Cytotechnologist work standard". (i) A limitation on the number of Pap smears (also known as gynecologic slides) and non-gynecologic slides a cytotechnologist may examine during a particular time period, or other limitation on the quantity, speed or manner of examination of slides by a cytotechnologist, under regulations of the department. (ii) Unless otherwise provided by the department, the cytotechnologist work standard shall be: No cytotechnologist may examine more than eighty one-slide gynecologic cases or fifty two-slide gynecologic cases per work day. If a cytotechnologist also examines non-gynecologic slides in a given work day the cytotechnologist's workload for gynecologic slides shall be correspondingly reduced, in accordance with written guidelines prepared by the clinical laboratory and filed with the department, so that a cytotechnologist examines no more than a total of one hundred gynecologic and non-gynecologic slides per work day.

(c) "Employ". To employ or contract with a cytotechnologist to examine gynecologic slides.

(d) "Clinical laboratory". A clinical laboratory issued a permit pursuant to this title.

(e) "Work day". A twenty-four hour period during which a cytotechnologist examines gynecologic slides for a clinical laboratory.

2. Compliance with cytotechnologist work standard. No cytotechnologist shall exceed the applicable cytotechnologist work standard. No clinical laboratory shall require, authorize, encourage or permit any cytotechnologist to exceed the applicable cytotechnologist work standard. In determining whether a cytotechnologist exceeds the applicable cytotechnologist work standard, all work done by the cytotechnologist during a given work day shall be considered, without regard to which clinical laboratory or other person for which or whom it was performed.

3. Registration of cytotechnologist. All cytotechnologists who are employed by a clinical laboratory must register with the department. The department shall, by regulation, prescribe a form and procedure for the registration of cytotechnologists. The registration form shall include at least the name, address, and an individual identification number determined by the department. The department shall notify each registrant of his or her identification number.

4. Employment of registered cytotechnologists. No clinical laboratory shall employ a cytotechnologist unless the cytotechnologist is registered under this section.

5. Record-keeping. (a) Each clinical laboratory shall maintain records, in a form prescribed by the department, which set forth, for each cytotechnologist employed by the clinical laboratory: (i) the name and identification number of the cytotechnologist; (ii) the number of hours worked by the cytotechnologist in each work day; [REV. 9/22/03 6] (iii) the number of gynecologic slides and non-gynecologic slides examined by the cytotechnologist, and how many were one-slide and two-slide cases, during each work day; and (iv) such other information as the department may require by regulation. (b) Each cytotechnologist shall maintain records, in a form prescribed by the department, which set forth: (i) the number of hours worked by the cytotechnologist in each work day; (ii) the number of gynecologic slides and non-gynecologic slides examined and how many were one-slide and two-slide cases, during each work day; (iii) the name and address of the clinical laboratory or other person for which or whom the slides were examined; and (iv) such other information as the department may require by regulation. (c) Such records of clinical laboratories and cytotechnologists shall be made available for inspection and copying by the department upon request.

6. Multiple employers. Whenever a cytotechnologist is employed by more than one clinical laboratory or other person during a work day, the cytotechnologist shall advise each clinical laboratory of any previous employment during the work day and the amount of work performed, to insure that the applicable cytotechnologist work standard is not exceeded.

7. Standards for gynecologic slides. (a) A gynecologic slide of a Pap smear shall not be tested or reported on if: (i) the apparent condition of the specimen indicates that it is unsatisfactory for testing or that it is inappropriate for the test requested; (ii) it has been collected, labeled, preserved or otherwise handled in such a manner that it has become unsatisfactory or unreliable as a test specimen; (iii) the slide is broken; (iv) it contains insufficient cells or the cells are obscured by inflammation, blood or lubricating ointment, so that an adequate diagnosis cannot be made; or (v) the slide is otherwise unsatisfactory, as defined by department regulations. (b) If the slide is unsatisfactory as set forth in this subdivision, the clinical laboratory shall have an affirmative duty to advise the collecting physician or other practitioner that the slide is unsatisfactory and request the submission of a new slide.

8. Re-examination of slides. The department shall prescribe, by regulation, a system of targeted re-examination of gynecologic slides examined and found to be not abnormal or questionable. The factors to be considered in the targeted re-examination may include, but are not limited to, the prior cancer and other history of the patient, the results of previous slide examinations, and the experience and ability of the cytotechnologist. Each clinical laboratory shall follow the prescribed re-examination system. REV. 9/22/03 7

9. Regulations. The department may, by regulation, establish cytotechnologist work standards. Those standards may include, but shall not be limited to, standards which take into account the experience and qualifications of the cytotechnologists and the performance of the clinical laboratory in proficiency testing programs conducted by the department. However, those standards shall not exceed by more than twenty percent the maximum numbers of slides which may be examined in a work day under clause (ii) of paragraph (b) of subdivision one of this section. Such standards shall be at least as stringent as federal standards promulgated under the federal clinical laboratory improvement amendments of nineteen hundred eighty-eight.

10. Notwithstanding any provisions of subdivisions one and nine of this section to the contrary, the department may, pursuant to regulation, increase the maximum number of slides which may be examined in a work day for clinical laboratories using slide examination or preparation technology approved by the federal food and drug administration, provided that such standards shall be at least as stringent as federal standards promulgated under the federal clinical laboratory improvement amendments of nineteen hundred eighty-eight or other applicable federal law.

11. Violations. (a) Sections twelve, twelve-a, and twelve-b of this chapter shall apply to violations of this section, except that the civil penalty for a violation of this section by a cytotechnologist shall not exceed five hundred dollars. (b) If a cytotechnologist violates this section, the department may suspend or revoke the cytotechnologist's registration under this section, pursuant to department regulations including appropriate due process protections for the cytotechnologist. (c) If any clinical laboratory or other person violating this section is licensed, certified or registered by the department under other provisions of law, the violation of this section may be grounds for disciplining the person under such law.

 

§ 576-b. Performance of certain clinical laboratory services upon request. 1. A clinical laboratory may perform a clinical laboratory service (including accepting a specimen or assignment for examination and rendering a report), that it is otherwise allowed to perform, upon the request of the person on whom the service is to be performed and render a report directly to the person, where the service is for the same purpose as a test or collection device that has been approved or cleared by the Food and Drug Administration of the United States Department of Health and Human Services for sale or distribution to the public on a direct or over-the-counter basis without a prescription from a qualified health care practitioner. '

 

§577. Enforcement. 1. A permit or certificate of qualification may be revoked, suspended, limited or annulled, or the holder thereof censured, reprimanded or otherwise disciplined by the department on proof that the certificate holder, owner or director, or one or more persons in his or her employ:

(a) has been guilty of misrepresentation in obtaining the permit or certificate or in the operation of the clinical laboratory or blood bank, including the submission to the department of proficiency test results obtained from another clinical laboratory;

(b) has knowingly accepted or permitted to be accepted a specimen or assignment for clinical laboratory examination from or rendered a report thereon to a person or persons not authorized by law to submit such assignment or specimen or receive such report;

(c) has engaged or attempted to engage or represented himself or herself as entitled to perform any procedure or category or procedures or services he or she is not authorized to perform; REV. 9/22/03 8

(d) has rendered a report on work actually performed in another clinical laboratory or blood bank without designating the fact that the examination or procedure was performed in another clinical laboratory or blood bank;

(e) has demonstrated incompetence or shown consistent errors in performance of examinations or procedures;

(f) has failed to file any report required by the provisions of this title or the rules and regulations promulgated thereunder;

(g) has violated or aided and abetted in the violation of any provision of this chapter, including this title, title six of this article, or the rules and regulations promulgated pursuant to this chapter or a violation of title eleven of article five of the social services law or the rules and regulations promulgated thereunder related to laboratory services; or

(h) has violated or aided and abetted in the violation of local laws, codes or regulations as specified in subdivision three of section five hundred eighty of this title.  

2. Proceedings under this section may be initiated by any person, corporation, association or public officer, or by the department, by filing written charges with the department.  

3. No permit or certificate shall be revoked, suspended, limited or annulled without a hearing, except as provided in subdivision three of section five hundred seventy-six of this title. However, a permit or certificate may be temporarily suspended without a hearing for a period not to exceed thirty days upon notice to the permit or certificate holder following a finding by the department that the public health, safety or welfare is in imminent danger.  

4. The commissioner shall set a time and place for the hearing. A copy of the charges, together with the notice of the time and place of the hearing, shall be mailed to the permit or certificate holder, at the address specified on the permit at least fifteen days before the date set for the hearing. The permit or certificate holder shall file with the department, not less than five days prior to the hearing, a written answer to the charges.  

5. Any person or entity which owns or operates a clinical laboratory and who does not hold a valid laboratory permit shall be liable to the people of the state for a civil penalty not to exceed two thousand dollars for each day for the unauthorized operation of the clinical laboratory. '

 

§578. Penalties.  

1. (a) A person who owns or operates a clinical laboratory or blood bank, and who does not hold a valid permit issued pursuant to the provisions of this title or who otherwise does not comply with this title or the New York city health code is guilty of a misdemeanor, punishable by imprisonment for not more than one year, or by a fine of not more than two thousand dollars, or by both such fine and imprisonment. For any subsequent offense, the penalty shall be both such fine and imprisonment. (b) A person who owns or operates a clinical laboratory or blood bank and willfully misreports laboratory results or otherwise fails to comply with the provisions of this title is guilty of a class A misdemeanor, punishable by imprisonment for not more than one year, or by a fine of not more than one thousand dollars, or by both such fine and imprisonment. REV. 9/22/03

2. A person who acts as a director after July first, nineteen hundred sixty-five, and who does not hold a valid certificate of qualification issued pursuant to the provisions of this title is guilty of a misdemeanor, punishable by imprisonment for not more than one year, or by a fine of not more than five hundred dollars or by both such fine and imprisonment.

 

§579. Scope and exceptions. 1. This title is applicable to all clinical laboratories and blood banks operating within the state, except clinical laboratories and blood banks operated by the federal government and clinical laboratories operated by a licensed physician, osteopath, dentist, midwife or podiatrist who performs laboratory tests or procedures, personally or through his or her employees, solely as an adjunct to the treatment of his or her own patients; to the extent authorized by law, including the education law, and consistent with any applicable written practice agreement. 2. This title shall not be applicable to and the department shall not have the power to regulate pursuant to this title: (a) any examination performed by a state or local government of materials derived from the human body for use in criminal identification or as evidence in a criminal proceeding or for investigative purposes; (b) any test conducted pursuant to paragraph (c) of subdivision four of section eleven hundred ninety-four of the vehicle and traffic law and paragraph (b) of subdivision four of section 25.24 of the parks, recreation and historic preservation law; (c) any examination performed by a state or local agency of materials derived from the body of an inmate, pretrial releasee, parolee, conditional releasee or probationer to (i) determine, measure or otherwise describe the presence or absence of any substance whose possession, ingestion or use is prohibited by law, the rules of the department of correctional services, the conditions of release established by the board of parole, the conditions of release established by a court or a local conditional release commission or the conditions of any program to which such individuals are referred and (ii) to determine whether there has been a violation thereof; or (d) any examination performed by a coroner or medical examiner for the medical-legal investigation of a death. Nothing herein shall prevent the department from consulting with the division of criminal justice services, the department of correctional services, the state police, or any other state agency or commission, at the request of the division of criminal justice services, the department of correctional services, the state police, or such other agency or commission, concerning examination of materials for purposes other than public health.

 

§580. Construction.  

1. Nothing in this title shall be construed as affecting the educational program of any college or university or any legally chartered school approved by the department of education which program is conducted for the training of its students. REV. 9/22/03 10 

2. Nothing in this title shall be construed as affecting facilities which perform laboratory tests solely for research purposes, nor as affecting laboratory testing by a public health officer as part of an epidemiological investigation in which no patient identified result is reported for diagnostic purposes to a health care provider or the subject of the test. 

3. (a) Nothing in this title shall be construed to impair or affect the power or authority of the city of New York or a department or agency thereof, to enact or enforce additional laws, codes or regulations affecting clinical laboratories or blood banks, not inconsistent with the provisions of this title or any regulations promulgated hereunder, related to the control, prevention or reporting of diseases or medical conditions or to the control or abatement of public health nuisances. Noncompliance with such laws, codes or regulations as documented by the local public health officer may be a basis for the department's denial or non-renewal of a laboratory permit or a certificate of qualification. (b) Such local laws, codes or regulations which are more restrictive than or additional to the requirements set forth in this title or the regulations promulgated hereunder shall be deemed not inconsistent.  

4. The collection, processing, storage, distribution or use of blood, blood components or blood derivatives for the purpose of diagnosis, prevention or treatment of disease is hereby declared to be a public health service and shall not be construed to be, and is declared not to be, a sale of such blood, blood components or blood derivatives, for any purpose or purposes whatsoever.

 

§581. Separability. If any clause, sentence, paragraph, section or part of this title shall be adjudged by any court of competent jurisdiction to be invalid, the judgment shall not affect, impair, or invalidate the remainder thereof, but shall be confined in its operation to the clause, sentence, paragraph, section, or part thereof directly involved in the controversy in which the judgment shall have been rendered. REV. 9/22/03 11

 

For more information about how to reduce your Workers' Compensation costs, send us an e-mail, or simply submit this short form.


"Workers Compensation Management Program: Reduce Costs 20% to 50%"

To learn more about how to lower your workers compensation expense, read the guidebook from Advisen and the Workers Comp Resource Center, Workers Compensation Management Program: Reduce Costs 20% to 50%, which covers the following:

•   BONUS CHAPTER! Process Overview for Workers Compensation Managers
Workers Compensation Basics
•   Fundamentals of Cost Containment
Best Practices Roles and Responsibilities
Management Commitment
Employee Communications
Controlling Fraud and Abuse
•   Return to Work and Transitional Duty
Claim Reporting
•   Other Indemnity Cost Containment Services
•   Directing Medical Care
Medical Cost Containment
Physical Therapy & Physical Rehabilitation
Pharmacy Benefits Management
Training Supervisors
Working with the Insurance Company and TPA
•   Claim Resolution and Settlement
•   Safety and Loss Control

Workers Compensation Management Program 2012: Reduce Costs 20-50%
Learn more about the comprehensive guidebook from Advisen and the Workers Comp Resource Center: Workers Compensation Management Program: Reduce Costs 20% to 50%.

Learn more: Workers Compensation Management Program: Reduce Costs 20% to 50%
Learn more about included documents, bulk pricing, and custom imprinted covers for brokers, carriers, and associations.



Recommend
Follow Us
Follow us on Twitter Follow us on LinkedIn Follow us on Facebook Follow us on YouTube Follow our Blog
Receive Our Workers'
Comp Newsletter


Twitter LinkedIn Facebook YouTube Blog RSS
Share

 

 

Top of Page